Bichara Guillermo sold $4.9M of LIN

Bichara Guillermo (Exec VP & Chief Legal Officer) sold 9,350 shares of LINDE PLC (LIN) at $518.91 ($4.85M total) on 2026-11-02.

Original reporting
SEC EDGAR · Bichara Guillermo
Published Nov 4, 2026, 5:21 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Nov 4, 2026, 5:25 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$LIN
Bearish
medium confidence
Mentioned
$LIN
Relevance
6/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$LINBearishLow
01

Why it matters

The filing provides fresh, material information about insider holdings, which can influence short‑term sentiment.

02

Market read

Primary insider sale; modest bearish implication for LIN stock.

03

What to watch

Potential tax planning or diversification motives for the insider.

Relevance 6/10Novelty 6/10Timing: today

Background

SEC Form 4 filing discloses an insider transaction for Linde plc (LIN).

Company-level read

Ticker impact

$LINBearishMedium confidence
Context

Exec VP & Chief Legal Officer Bichara Guillermo sold 9,350 shares for $4.85M, reducing his stake to 22,138 shares.

Expected impact

likely modest downward pressure as the market prices the insider sell.

Evidence & confidence

A $4.9M sale by a senior legal officer is material but not large enough to trigger a sharp move; investors may view it as a mild bearish signal.

Market effects

Minimal impact on the industrial gases sector; the sale is company‑specific.

No broader regional effect; confined to LIN investors.

Limited global relevance; only affects LIN shareholders.

Counterpoint

The sale could be routine portfolio rebalancing, not a negative signal.

Key entities

  • Bichara Guillermo

    Executive Vice President & Chief Legal Officer of Linde plc.

  • Linde plc

    Global industrial gases company listed on NYSE under ticker LIN.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$LINMedAI 8/10

Linde PLC (LIN) (Q3 2026) Earnings Call Highlights: Record Sales, Profit and EPS

Linde PLC (LIN) reported Q3 2026 record sales, profit, and EPS, but faced challenges in non-gas segments like Lincare, which reduced EPS growth by 2%. Q4 EPS guidance is $4.40-$4.50, a 3% sequential decline due to FX headwinds and seasonality. Europe and China markets remain weak. Management is evaluating strategic options for Lincare and expects no near-term recovery in Europe or China. Electronics growth is strong, supported by $2B in projects.

$LINMed

Linde plc Q3 2026 Earnings Call Summary

Linde plc reported Q3 2026 earnings, including a $425M restructuring charge. Lincare was moved to the Global Other segment. Chemicals and Energy grew 12%, Electronics 15%. Q4 EPS guidance is $4.40-$4.50. Management expects restructuring benefits by H2 2027 and Woodside ammonia project completion by H1 2027.

$LINMedAI 8/10

Linde Q3 Earnings Call Highlights

Linde (LIN) reported varied demand across regions and sectors in Q3, with electronics sales up 15% and chemicals/energy up 12%. U.S. packaged-gas growth remained in the low teens, while Europe saw flat market conditions. Linde's project backlog is near $8 billion, with the Woodside project expected to contribute financially in 2024. The company forecasted Q4 EPS of $4.40-$4.50, with full-year EPS at $17.82-$17.92.

$LINHighAI 8/10

Linde delivers a good quarter and puts in a fix for an overhang on the stock

Linde reported record Q3 revenue of $9.4B, up 9.2%, and adjusted EPS of $4.59, beating estimates. Shares fell 1% despite strong results due to light Q4 guidance. CEO addressed Lincare restructuring, taking a $425M charge. Sales grew in electronics, chemicals, and energy, with space propellant demand noted. Full-year EPS outlook raised to $17.87, in line with consensus. Linde maintains a $550 price target.